Intel (INTC)

Financing Cash Flow

$2.45B

TTM · Period ending: · USD

INTC logo

INTC Financing Cash Flow

Latest reported$2.45B
INTC TTM Cash from Financing ($416.90M → $2.45B)
High-resolution chart · PNG

INTC financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Intel Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
2,453,000,000
10,577,000,000
11,587,000,000
5,801,000,000
-3,143,000,000
7,312,000,000
11,138,000,000
11,227,000,000
15,861,000,000
4,741,000,000
8,505,000,000
10,696,000,000
13,534,000,000
10,615,000,000
1,358,000,000
-4,791,000,000
-4,565,000,000
-4,051,000,000
-5,862,000,000
-3,753,000,000
-20,452,000,000
-21,355,000,000
-12,917,000,000
-16,364,000,000
-9,304,000,000
-10,699,000,000
-17,565,000,000
-17,889,000,000
-16,763,000,000
-19,337,000,000
-18,607,000,000
-20,792,000,000
-18,745,000,000
-8,101,000,000
-8,475,000,000
-4,720,000,000
-4,368,000,000
-6,703,000,000
-5,739,000,000
-1,753,000,000
6,498,000,000
3,404,000,000
1,912,000,000
-2,615,000,000
-13,265,000,000
-14,235,000,000
-13,611,000,000
-10,494,000,000
-7,193,000,000
-5,410,000,000
-5,498,000,000
91,000,000
-607,000,000
-1,651,000,000
-1,408,000,000
-9,525,000,000
-7,338,000,000
-7,907,000,000
-11,100,000,000
-9,847,000,000
-10,679,000,000
-8,924,000,000
-4,642,000,000
-2,803,000,000
-2,494,000,000
-2,373,000,000
-2,568,000,000
-2,771,000,000
-4,761,000,000
-6,901,000,000
-9,018,000,000
-9,204,000,000
-7,455,000,000
-4,246,000,000
-1,990,000,000
-1,283,000,000
-2,170,000,000
-3,726,000,000
-6,439,000,000
-7,689,000,000
-8,916,000,000
-10,166,000,000
-9,544,000,000
-10,035,000,000
-9,854,000,000
-8,932,000,000
-7,651,000,000
-7,431,000,000
-4,712,000,000
-4,077,000,000
-3,858,000,000
-2,885,000,000
-4,169,000,000
-4,130,000,000
-3,930,000,000
-3,837,000,000
-3,751,000,000
-3,568,000,000
-3,465,000,000
-3,548,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.